 |
Return Create A Forum - Home |
 |
--------------------------------------------------------- |
|
MS Speaks |
 |
https://msspeaks.createaforum.com |
|
--------------------------------------------------------- |
|
***************************************************** |
|
Return to: ZEPOSIA (ozanimod) |
|
***************************************************** |
|
#Post#: 3992-------------------------------------------------- |
|
FDA-approved drugs not recommended for use or reimbursement in |
|
other countries, 2017-2020 |
|
By: agate Date: April 12, 2023, 1:29 am |
|
--------------------------------------------------------- |
|
This is a long and complex article and is provided here only |
|
because one of the drugs that received negative recommendations |
|
was ozanimod. Table 4 shows ozanimod listed as a drug of |
|
"uncertain clinical benefit" according the assessments by CADTH |
|
(Canadian Agencies for Drugs and Technologies in Health) and |
|
NICE (UK National Institute for Health and Care Excellence). |
|
From JAMA Internal Medicine (February 13, 2023)--"Assessment of |
|
FDA-approved drugs not recommended for use or reimbursement in |
|
other countries, 2017-2020": |
|
http://bit.ly/3MyqDerhttp://bit.ly/3MyqDer |
|
***************************************************** |
